A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)
Phase of Trial: Phase III
Latest Information Update: 11 Aug 2018
At a glance
- Drugs Anastrozole (Primary)
- Indications Adenocarcinoma; Advanced breast cancer; Breast cancer
- Focus Biomarker; Pharmacogenomic; Therapeutic Use
- 31 Jul 2018 Planned End Date changed from 1 Jan 2020 to 1 Jan 2025.
- 10 Jun 2017 Biomarkers information updated
- 11 Jul 2013 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.